JP2001519410A5 - - Google Patents

Download PDF

Info

Publication number
JP2001519410A5
JP2001519410A5 JP2000515866A JP2000515866A JP2001519410A5 JP 2001519410 A5 JP2001519410 A5 JP 2001519410A5 JP 2000515866 A JP2000515866 A JP 2000515866A JP 2000515866 A JP2000515866 A JP 2000515866A JP 2001519410 A5 JP2001519410 A5 JP 2001519410A5
Authority
JP
Japan
Prior art keywords
formula
embedded image
ring
alkyl
compound represented
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2000515866A
Other languages
English (en)
Japanese (ja)
Other versions
JP2001519410A (ja
Filing date
Publication date
Priority claimed from US09/161,653 external-priority patent/US6005102A/en
Application filed filed Critical
Priority claimed from PCT/US1998/021609 external-priority patent/WO1999019293A1/en
Publication of JP2001519410A publication Critical patent/JP2001519410A/ja
Publication of JP2001519410A5 publication Critical patent/JP2001519410A5/ja
Pending legal-status Critical Current

Links

JP2000515866A 1997-10-15 1998-10-14 新規なアリールオキシ−アルキル−ジアルキルアミン Pending JP2001519410A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US95081897A 1997-10-15 1997-10-15
US08/950,818 1997-10-15
US09/161,653 US6005102A (en) 1997-10-15 1998-09-28 Aryloxy-alkyl-dialkylamines
US09/161,653 1998-09-28
PCT/US1998/021609 WO1999019293A1 (en) 1997-10-15 1998-10-14 Novel aryloxy-alkyl-dialkylamines

Publications (2)

Publication Number Publication Date
JP2001519410A JP2001519410A (ja) 2001-10-23
JP2001519410A5 true JP2001519410A5 (enExample) 2006-03-16

Family

ID=26858006

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000515866A Pending JP2001519410A (ja) 1997-10-15 1998-10-14 新規なアリールオキシ−アルキル−ジアルキルアミン

Country Status (26)

Country Link
EP (2) EP1777214A3 (enExample)
JP (1) JP2001519410A (enExample)
KR (1) KR100669836B1 (enExample)
CN (1) CN1231458C (enExample)
AR (1) AR015183A1 (enExample)
AT (1) ATE355264T1 (enExample)
AU (1) AU757630C (enExample)
BR (1) BR9813069A (enExample)
CA (1) CA2306343C (enExample)
CY (1) CY1106497T1 (enExample)
DE (1) DE69837210T2 (enExample)
DK (1) DK1025077T3 (enExample)
EA (1) EA003937B1 (enExample)
EE (1) EE200000225A (enExample)
ES (1) ES2281937T3 (enExample)
HU (1) HUP0004419A3 (enExample)
ID (1) ID24417A (enExample)
IL (2) IL135343A0 (enExample)
NO (1) NO20001938L (enExample)
NZ (1) NZ503793A (enExample)
PL (1) PL198443B1 (enExample)
PT (1) PT1025077E (enExample)
SI (1) SI1025077T1 (enExample)
SK (1) SK286460B6 (enExample)
TR (1) TR200001012T2 (enExample)
WO (1) WO1999019293A1 (enExample)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GEP20033079B (en) * 1998-05-15 2003-10-27 Wyeth Corp Pharmaceutical Compositions for Treatment of Diseases Caused by Estrogens Deficiency
US6479535B1 (en) 1998-05-15 2002-11-12 Wyeth 2-phenyl-1-[4-(2-aminoethoxy)-benzyl]-indole and estrogen formulations
TWI287018B (en) * 1999-09-13 2007-09-21 Wyeth Corp Glucopyranosides conjugates of 2-(4-hydroxy-phenyl)-3-methyl-1-[4-(2-amin-1-yl-ethoxy)-benzyl]-1H-indol-5-ols
US6376486B1 (en) 2000-07-06 2002-04-23 American Home Products Corporation Methods of inhibiting sphincter incontinence
AU2001273144A1 (en) 2000-07-06 2002-01-21 Wyeth Use of substituted indole compounds for treating neuropeptide y-related conditions
AR029539A1 (es) 2000-07-06 2003-07-02 Wyeth Corp Combinaciones de estatinas y agentes estrogenicos
US6369051B1 (en) 2000-07-06 2002-04-09 American Home Products Corporation Combinations of SSRI and estrogenic agents
WO2002003975A2 (en) 2000-07-06 2002-01-17 Wyeth Combinations of ssri and estrogenic agents
EP1656938A1 (en) 2000-07-06 2006-05-17 Wyeth Combinations of SSRI and estrogenic agents
WO2002003990A2 (en) 2000-07-06 2002-01-17 Wyeth Use of substituted insole compounds for treating excessive intraocular pressure
US6455568B2 (en) 2000-07-06 2002-09-24 Wyeth Combination therapy for inhibiting sphincter incontinence
AR029538A1 (es) 2000-07-06 2003-07-02 Wyeth Corp Composiciones farmaceuticas de agentes estrogenicos
AU2002254114A1 (en) * 2001-03-23 2002-10-08 Eli Lilly And Company Non-imidazole aryl alkylamines compounds as histamine h3 receptor antagonists, preparation and therapeutic uses
JP2004531559A (ja) 2001-05-22 2004-10-14 イーライ・リリー・アンド・カンパニー エストロゲン欠乏または内因性エストロゲンに対する異常な生理反応に関連する疾患を抑制するためのテトラヒドロキノリン誘導体
WO2002094788A1 (en) 2001-05-22 2002-11-28 Eli Lilly And Company 2-substituted 1,2,3,4-tetrahydroquinolines and derivatives thereof, compositions and methods
US7314937B2 (en) 2002-03-21 2008-01-01 Eli Lilly And Company Non-imidazole aryl alkylamines compounds as histamine H3 receptor antagonists, preparation and therapeutic uses
US7098241B2 (en) 2002-12-16 2006-08-29 Hoffmann-La Roche Inc. Thiophene hydroxamic acid derivatives
BRPI0509257A (pt) * 2004-04-07 2007-09-11 Wyeth Corp polimorfo cristalino de acetato de bazedoxifeno, composição, processo para preparar um polimorfo e para aumentar a proporção de acetato de bazedoxifeno forma b em uma composição, métodos de tratar um mamìfero, cáncer de mama e uma mulher em pós-menopausa para um ou mais distúrbios vasomotores, de abaixar colesterol e de inibir perda óssea em um mamìfero e uso de um polimorfo
BRPI0509191A (pt) * 2004-04-07 2007-09-25 Wyeth Corp polimorfo cristalino, composição, métodos de preparar forma a polimórfica de acetato de bazedoxifeno, de tratar um mamìfero possuindo uma doença ou sìndrome associada com deficiência de estrogênio ou excesso de estrogênio, e com proliferação ou desenvolvimento anormal de tecidos endometriais, cáncer de mama em um mamìfero, e uma mulher pós-menopausal para um ou vários distúrbios vasomotores, de abaixar colesterol em um mamìfero, e de inibir perda óssea em um mamìfero, e, forma a polimorfa cristalina de acetato de bazedoxifeno
CN1946689A (zh) 2004-04-08 2007-04-11 惠氏公司 作为选择性雌激素受体调节剂的巴西多昔芬抗坏血酸盐
CA2575618A1 (en) * 2004-08-05 2006-02-16 Wyeth Crystalline polymorph of pipindoxifene hydrochloride monohydrate
PE20060874A1 (es) * 2005-01-13 2006-10-16 Wyeth Corp Procedimientos para la preparacion de alcoholes aminoetoxibencilicos
US20100087661A1 (en) * 2007-02-12 2010-04-08 Josef Jirman Method for the preparation of 5-benzyloxy-2-(4-benzyloxphenyl)-3-methyl-1h-indole
US20100016582A1 (en) * 2008-02-11 2010-01-21 Wyeth Methods of converting polymorphic form b of bazedoxifene acetate to polymorphic form a of bazedoxifene acetate
AU2010237209A1 (en) * 2009-04-13 2011-09-01 Sandoz Ag Processes for the synthesis of bazedoxifene acetate and intermediates thereof
US8569483B2 (en) 2011-06-21 2013-10-29 Divi's Laboratories, Ltd. Process for the preparation of bazedoxifene acetate and intermediates thereof
CN104151265B (zh) * 2013-05-13 2016-10-05 上海医药工业研究院 醋酸巴多昔芬中间体的制备方法
WO2014186325A1 (en) 2013-05-15 2014-11-20 Indiana University Research And Technology Corporation Processes and intermediates for preparing indole pharmaceuticals
IT201800006562A1 (it) * 2018-06-21 2019-12-21 Procedimento e intermedi utili per la preparazione di indoli
IT201900001923A1 (it) 2019-02-11 2020-08-11 Erregierre Spa Sali di bazedoxifene utili per la preparazione di bazedoxifene acetato

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH448121A (de) 1963-03-13 1967-12-15 Hoffmann La Roche Verfahren zur Herstellung substituierter Hydrazinverbindungen
WO1991007107A1 (en) * 1989-11-13 1991-05-30 Pfizer Inc. Oxazolidinedione hypoglycemic agents
GB9326332D0 (en) 1993-12-23 1994-02-23 Karo Bio Indole derivatives
IL121202A (en) * 1996-07-01 2001-08-26 Lilly Co Eli Hypoglycemic and hypolipidemic compounds, process for their preparation, pharmaceutial compositions comprising same, and uses thereof
DE69823019T2 (de) * 1997-02-27 2005-03-31 Wyeth Holdings Corp. N-hydroxy-2-(alkyl, aryl oder heteroaryl sulfanyl, sulfinyl oder sulfonyl)-3-substituierte alkyl-, aryl- oder heteroarylamide als matrixmetalloproteinaseinhibitoren
CA2287980A1 (en) * 1997-04-30 1998-11-05 Daniel Jon Sall Antithrombotic agents

Similar Documents

Publication Publication Date Title
JP2001519410A5 (enExample)
JP2003519676A5 (enExample)
JP2002543183A5 (enExample)
JP2004501940A5 (enExample)
JP2003501474A5 (enExample)
JP2005502658A5 (enExample)
JP2002502874A5 (enExample)
JP2002508362A5 (ja) １−置換−１−アミノメチル−シクロアルカン誘導体（＝ガバペンチン類縁体）
JP2002508352A5 (ja) ４(３)置換−４(３)−アミノメチル−（チオ）ピラン又はピペリジン誘導体（＝ガバペンチン類似体）
JP2001519443A5 (enExample)
JP2001526218A5 (enExample)
KR850002469A (ko) 피세나돌 전구체 및 그의 중간체의 제조방법
JP2002539156A5 (enExample)
EP0185324A3 (en) Novel organic trithio oxides and method for the preparation thereof
JP2002511433A5 (enExample)
KR920019777A (ko) 치환된 3-(피리딘일아미노)-인돌 및 벤조[b]티오펜, 이의 제조방법 및 약제로서의 이의 용도
EP0233686A3 (en) Bis phenyl ethanol amines and bis phenyoxypropanolamines having a beta-agonist activity
EP1335247A3 (en) Light sensitive composition, light sensitive planographic printing plate precursor, and image formation method
JP2002523496A5 (enExample)
RU2004107847A (ru) Изоксазолпиридиноны и их применение в лечении болезни паркинсона
KR910000647A (ko) 나프틸아미노-및 나프틸옥시- 피리딘아민 및 관련된 화합물, 이의 제조방법 및 이의 피부소염제로서의 용도
JP2003509494A5 (enExample)
KR880011063A (ko) 프로피올로페논 유도체
CA2281695A1 (en) Process for the preparation of substituted thiazolidinedione
KR910007923A (ko) 3-(l-피로글루타밀)-l-티아졸리딘-4-카르복실산과 그 유도체의 제조방법